Successful treatment of chronic hepatitis C with ground ledipasvir/sofosbuvir in a patient with Crohn's disease and short bowel syndrome
J Viral Hepat
.
2018 Feb;25(2):214-215.
doi: 10.1111/jvh.12768.
Epub 2017 Aug 30.
Authors
J von Felden
1
,
C Scheurich
1
,
J Yamamura
2
,
D M Brainard
3
,
E Mogalian
3
,
A W Lohse
1
,
J Schulze Zur Wiesch
1
Affiliations
1
Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
2
Department for Diagnostic and Interventional Radiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
3
Gilead Sciences Inc, Foster City, CA, USA.
PMID:
28783205
DOI:
10.1111/jvh.12768
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiviral Agents
Benzimidazoles
Crohn Disease
Fluorenes
Hepatitis C, Chronic*
Humans
Short Bowel Syndrome
Sofosbuvir*
Substances
Antiviral Agents
Benzimidazoles
Fluorenes
ledipasvir
Sofosbuvir